UnitedHealth Group consensus holds steady, shares tracked on NYSE

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 15:09.

UnitedHealth Group (US91324P1021) remains closely followed on the NYSE, where it is a key component of the Dow Jones Industrial Average. The health insurer presents a consistent analyst consensus profile, with major houses maintaining broadly positive views on the stock per MarketScreener and other coverage pages. MarketScreener consensus overview

How analysts currently rate UnitedHealth

Coverage of UnitedHealth Group by large brokerages remains extensive, with more than 20 active analyst ratings listed on MarketScreener as of late June 2026. Several houses, including Goldman Sachs and JPMorgan, continue to assign Buy or Overweight ratings, signalling confidence in the company’s managed care and health services model. Recent Reuters commentary on UnitedHealth

Recent consensus data compiled by MarketScreener indicates that the average twelve-month price target for UnitedHealth Group still implies upside from current trading levels, although dispersion among individual targets has widened modestly in 2026. The majority of recommendations cluster around Buy and Outperform, while only a small minority of analysts rate the stock Hold, and Sell ratings are rare in the current sample.

Earnings expectations and calendar

UnitedHealth Group follows a regular quarterly reporting cycle, with its next earnings release for the second quarter of 2026 currently expected around mid-July based on the company’s historical schedule and exchange calendar data. The insurer typically reports before the market opens on the NYSE, offering investors early insight into trends in its UnitedHealthcare insurance segment and Optum health services arm.

Consensus forecasts for the upcoming quarter point to continued revenue growth and stable margins, reflecting expectations for ongoing enrollment and demand for health services across the United States. Analysts closely track medical cost ratios, premium trends and Optum’s contribution to operating profit, as these metrics significantly shape their earnings models and valuation work on UnitedHealth Group.

What UnitedHealth Group sells

UnitedHealth Group earns most of its revenue through health insurance plans under the UnitedHealthcare brand and through health services offered by Optum, including pharmacy benefit management, care delivery and data analytics solutions. These activities position the company as one of the largest health care payers and service providers in the United States.

Where the stock trades today

UnitedHealth Group shares trade on the NYSE under the ticker UNH, with the latest available price data indicating the stock changing hands near recent 2026 levels in US dollars as of the most recent session.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.